Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

bmiMD vs Maves

bmiMD
Graded #26

Higher grade

vs+12.400000000000006
Maves
Graded #91

Lower grade

The verdict

bmiMD takes it — 84/100 to 71.6/100.

bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Among the cheapest both-molecule pairings ($99/$139), nationwide — but not LegitScript-listed.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuebmiMD +11
94
83
Dose & formulationbmiMD +15
80
65
Clinical oversightbmiMD +3
79
76
Labs & monitoringbmiMD +26
78
52
FulfillmentMaves +1
86
87
Contract termsbmiMD +28
83
55
bmiMD · left barMaves · right bar

The numbers

MetricbmiMDMaves
WeighScore84/10071.6/100
GradeBC
Scorecard rank#26#91
Semaglutide$99/mo$99/mo (starting dose, first-month rate, compounded)
Tirzepatide$139/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
bmiMD

Graded #26 · B

Strengths

  • $99 sema / $139 tirz
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Injection-only
  • Thin oversight/monitoring detail
Maves

Graded #91 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard